ProShare Advisors LLC Grows Position in DocGo Inc. (NASDAQ:DCGO)

ProShare Advisors LLC lifted its position in DocGo Inc. (NASDAQ:DCGO) by 49.0% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 28,641 shares of the company’s stock after purchasing an additional 9,425 shares during the period. ProShare Advisors LLC’s holdings in DocGo were worth $121,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds have also recently added to or reduced their stakes in DCGO. Summit Investment Advisors Inc. raised its position in shares of DocGo by 38.7% in the fourth quarter. Summit Investment Advisors Inc. now owns 10,639 shares of the company’s stock worth $45,000 after acquiring an additional 2,968 shares during the period. Prudential Financial Inc. purchased a new position in shares of DocGo in the 4th quarter valued at about $55,000. Royce & Associates LP acquired a new position in DocGo in the 4th quarter worth about $64,000. Boothbay Fund Management LLC boosted its position in DocGo by 154.9% during the fourth quarter. Boothbay Fund Management LLC now owns 27,445 shares of the company’s stock worth $116,000 after purchasing an additional 77,445 shares in the last quarter. Finally, Jefferies Financial Group Inc. purchased a new position in DocGo during the fourth quarter worth approximately $123,000. 56.44% of the stock is owned by hedge funds and other institutional investors.

DocGo Stock Performance

NASDAQ DCGO opened at $1.49 on Tuesday. The business has a fifty day moving average price of $2.05 and a 200 day moving average price of $3.42. The company has a market cap of $151.95 million, a P/E ratio of 5.32, a P/E/G ratio of 14.16 and a beta of 1.14. DocGo Inc. has a one year low of $1.23 and a one year high of $5.68.

DocGo (NASDAQ:DCGO) last released its earnings results on Thursday, May 8th. The company reported ($0.09) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.01) by ($0.08). The business had revenue of $96.03 million for the quarter, compared to analysts’ expectations of $104.25 million. DocGo had a return on equity of 8.90% and a net margin of 4.35%. As a group, sell-side analysts predict that DocGo Inc. will post 0.25 EPS for the current fiscal year.

Wall Street Analyst Weigh In

Several brokerages have recently weighed in on DCGO. BTIG Research downgraded DocGo from a “buy” rating to a “neutral” rating in a research note on Friday, May 9th. Deutsche Bank Aktiengesellschaft cut shares of DocGo from a “buy” rating to a “hold” rating and reduced their price objective for the stock from $5.00 to $2.85 in a research report on Friday, February 28th. Needham & Company LLC decreased their price objective on shares of DocGo from $4.00 to $3.00 and set a “buy” rating on the stock in a report on Friday, May 9th. Canaccord Genuity Group reissued a “hold” rating and set a $1.45 target price (down previously from $5.00) on shares of DocGo in a research note on Monday, May 12th. Finally, Stifel Nicolaus reduced their price target on shares of DocGo from $6.50 to $5.50 and set a “buy” rating for the company in a research report on Friday, February 28th. Three investment analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus target price of $3.56.

DocGo Profile

DocGo Inc provides mobile health and medical transportation services for various health care providers in the United States and the United Kingdom. The company's transportation services include emergency response services; and non-emergency transport services comprise ambulance and wheelchair transportation services.